2020 ASCO Virtual Direct™ Highlights

 

Breast
11:09

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on HER2+ mBC: Does T-DXd Dosage Change How Effective and Safe It Is? Is Tucatinib/Trastuzumab/Capecitabine Combo Beneficial for PFS?

FEATURING Anthony Elias
  • 72 views
  • December 1, 2020
07:38

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on mBC: What Are the Response Rates With Olaparib? Does Palbociclib Improve PFS in Combination With Fulvestrant/Letrozole in ER+ Disease?

FEATURING Anthony Elias
  • 21 views
  • December 1, 2020
06:45

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on 1L mTNBC: Does Pembro+Chemo Improve PFS vs. Chemo Alone?

FEATURING Anthony Elias
  • 12 views
  • December 1, 2020
07:23

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HR+ BC: Fulvestrant / Fulvestrant + Anastrozole vs. Anastrozole - Which Option Significantly Improved Endocrine-sensitive Disease Rate in Postmenopausal Women With Locally Advanced BC?

FEATURING Reshma L. Mahtani
  • 126 views
  • August 6, 2020
06:29

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HR+ BC: Is There a Prognostic Utility of MammaPrint for CT Untreated C-High/G-Low Risk Women After 8.7 Years?

FEATURING Reshma L. Mahtani
  • 94 views
  • August 19, 2020
09:38

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HER2+ BC: Does Replacing Adjuvant Taxane & Trastuzumab With T-DM1 Improve Efficacy? Do Higher-risk Stage II and III Patients Require Anthracyclines-containing Regimen?

FEATURING Reshma L. Mahtani
  • 322 views
  • August 19, 2020
  • 1
08:28

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on BC: Does Maintenance Therapy With Metronomic Capecitabine Significantly Improve DFS in Operable TNBC? Is There Survival Benefit With Early Local Therapy?

FEATURING Reshma L. Mahtani
  • 195 views
  • August 19, 2020